Physician profile
Nigel N Walters
NPI 1326073750
$4,655.16
in general payments reported to CMS, 2019-2025
16 companies · $1,311 in 2025
The $1,311 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $570 · 2022: $289 · 2023: $904 · 2024: $1,581 · 2025: $1,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,635 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,635.11 |
| Education | $161.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,193.14 | 2021-2025 | Proclaim, Eterna, Freestyle Libre 3 |
| Novo Nordisk INC | $569.20 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $433.01 | 2024-2025 | Mounjaro, Zepbound, Trulicity |
| Spinal Simplicity, LLC | $289.96 | 2024-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $257.63 | 2021-2023 | |
| Pfizer INC. | $228.91 | 2024-2025 | |
| Foundation Fusion Solutions, LLC | $196.55 | 2023 | |
| Corcept Therapeutics | $84.11 | 2024-2025 | Korlym |
| Dexcom, INC. | $71.01 | 2024-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $67.74 | 2025 | Recorlev |
| Exact Sciences Corporation | $62.32 | 2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $58.30 | 2024 | Nexletol |
| Agios Pharmaceuticals, INC. | $49.56 | 2024 | Pyrukynd |
| Radius Health, INC. | $44.25 | 2025 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.14 | 2024-2025 | Xifaxan, Trulance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $17.33 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nigel Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.